======= HMMR =======
== Gene Information ==
* **Official Symbol**: HMMR
* **Official Name**: hyaluronan mediated motility receptor
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=3161|3161]]
* **UniProt**: [[https://www.uniprot.org/uniprot/O75330|O75330]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=HMMR&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20HMMR|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/600936|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: The protein encoded by this gene is involved in cell motility. It is expressed in breast tissue and together with other proteins, it forms a complex with BRCA1 and BRCA2, thus is potentially associated with higher risk of breast cancer. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Dec 2008].
* **UniProt Summary**: Receptor for hyaluronic acid (HA) (By similarity). Involved in cell motility (By similarity). When hyaluronan binds to HMMR, the phosphorylation of a number of proteins, including PTK2/FAK1 occurs. May also be involved in cellular transformation and metastasis formation, and in regulating extracellular- regulated kinase (ERK) activity. May act as a regulator of adipogenisis (By similarity). {ECO:0000250|UniProtKB:Q00547}.
No Pfam Domain information is available for this gene.
|hyaluronan catabolic process|
|hyaluronic acid binding|
|hyaluronan metabolic process|
|glycosaminoglycan catabolic process|
|aminoglycan catabolic process|
|mucopolysaccharide metabolic process|
|microtubule cytoskeleton|
|glycosaminoglycan metabolic process|
|aminoglycan metabolic process|
|carbohydrate derivative catabolic process|
|regulation of G2/M transition of mitotic cell cycle|
|regulation of cell cycle G2/M phase transition|
|organic acid catabolic process|
|carboxylic acid catabolic process|
|regulation of mitotic cell cycle phase transition|
|small molecule catabolic process|
|regulation of cell cycle phase transition|
|centrosome|
|cell surface|
|regulation of mitotic cell cycle|
|regulation of cell cycle process|
|carboxylic acid metabolic process|
|oxoacid metabolic process|
|organic acid metabolic process|
|carbohydrate derivative metabolic process|
|macromolecule catabolic process|
|organonitrogen compound catabolic process|
|regulation of cell cycle|
|small molecule metabolic process|
|organic substance catabolic process|
|cellular catabolic process|
|membrane|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp231|Epothilone-B 0.0015μM R05 exp231]]|-2.49|
|[[:results:exp103|Taxol 0.004μM R03 exp103]]|-2.48|
|[[:results:exp217|Mdivi-1 15μM R05 exp217]]|-2.32|
|[[:results:exp525|Sulforaphane 9μM R08 exp525]]|-1.85|
|[[:results:exp190|Vincristine 0.0005μM R04 exp190]]|-1.83|
|[[:results:exp312|2-Methoxyestradiol 0.55 to 1μM on day4 R07 exp312]]|-1.7|
|[[:results:exp438|NN-Diethyl-meta-toluamide 500μM R08 exp438]]|1.71|
|[[:results:exp475|CyclicAMP 200μM R08 exp475]]|1.95|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 17797
* **Expression level (log2 read counts)**: 6.45
{{:chemogenomics:nalm6 dist.png?nolink |}}